Callio Therapeutics has raised $187m in Series A financing round for achieving clinical proof-of-concept for HER2-targeted ...

Experts debate whether European manufacturers are preferring domestic operations as the continent competes with Asia and the ...

Widespread integration of machine learning (ML) into supply chain management by major pharma suppliers is just a few years ...

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

Cell and gene therapies have undergone notable milestones in the last 12 months, with solid tumors and diabetes treatments.

AstraZeneca's Imfinzi (durvalumab) plus chemotherapy, has gained CHMP recommendation for approval in the EU to treat NSCLC.

Nuvation Bio has secured $250m in non-dilutive financing from Sagard, aimed at funding the commercialisation of taletrectinib ...

At MWC Barcelona 2025, Li Peng delivered a keynote on how carriers can make the most of AI to fully unleash the value of ...

As the field of regenerative medicine continues to advance, the incorporation of AI is playing a transformative role in the ...

Download our expert guide for real world data pharmaceutical solutions. Discover what to explore leading RWE and RWD providers to enhance patient outcomes and drive innovation in the pharmaceutical ...

The EC has authorised the marketing of Bavarian Nordic's Vimkunya chikungunya vaccine for individuals as young as 12 years ...

Novo Nordisk and AI-driven protein design company Gensaic are to develop tissue-targeted therapies for cardiometabolic ...